Table 1 Patient demographics
Characteristic | DD group (n = 62) | DT group (n = 60) | DC group (58) | F/χ2 /K-W | P value |
|---|---|---|---|---|---|
Age, yr | 43.41 ± 1.35 | 43.85 ± 1.15 | 43.63 ± 1.28 | 0.068(F) | 0.934 |
Height, m | 1.62 ± 0.01 | 1.62 ± 0.01 | 1.61 ± 0.01 | 0.357(F) | 0.700 |
Weight, kg | 61.80 ± 1.03 | 62.05 ± 1.30 | 60.82 ± 1.15 | 0.357(F) | 0.700 |
BMI, kg/m2 | 23.59 ± 0.41 | 23.74 ± 0.46 | 23.46 ± 0.44 | 0.132(F) | 0.876 |
ASA class n(%) | |||||
I | 8(12.9%) | 14(23.3%) | 12(20.7%) | 2.346(χ2) | 0.309 |
II | 54(87.1%) | 46(76.7%) | 46(79.3%) | ||
Apfel score n(%) | |||||
2 | 39(62.9%) | 32(53.3%) | 40(69.0%) | 3.110(χ2) | 0.211 |
3 | 23(37.1%) | 28(46.7%) | 18(31.0%) | ||
Type of surgery, n(%) | |||||
Hysteroscope | 46(75.4%) | 40(66.7%) | 44(75.9%) | 1.698(χ2) | 0.791 |
Cervical conization | 14(23.0%) | 19(31.7%) | 13(22.4%) | ||
Others | 1(1.6%) | 1(1.7%) | 1(1.7%) | ||
Duration of anesthesia, min Median (Range) | 23.00(20.00–30.00) | 24.50(16.00–36.75) | 24.50(17.50–29.50) | 0.009(K-W) | P = 0.996 |
Dose, mg | |||||
Remimazolam, induction | 16.38 ± 0.41 | 15.84 ± 0.48 | 15.31 ± 0.36 | 1.287(F) | 0.279 |
Remimazolam, maintenance,Median (Range) | 13.87(8.67–20.85) | 14.80(9.70–20.75) | 15.00(10.00–23.00) | 0.771(K-W) | 0.680 |
Alfentanil, induction,Median (Range) | 1.00(1.00–1.00) | 1.00(1.00–1.00) | 1.00(1.00–1.10) | 1.908(K-W) | 0.385 |
Alfentanil, maintenance,Median (Range) | 0.46(0.32–0.68) | 0.57(0.37–1.06) | 0.56(0.40–0.90) | 4.749(K-W) | 0.093 |
Mivacurium Chloride induction,Median (Range) | 10.00(10.00–10.00) | 10.00(10.00–10.00) | 10.00(10.00–12.00) | 1.834(K-W) | 0.400 |